Cancer group denies company funding will influence its agendaBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7574.874-b (Published 26 October 2006) Cite this as: BMJ 2006;333:874
- Rory Watson
The organisers of a pan-European cancer campaign have denied claims that they are in the pocket of the drug industry. The new organisation, Cancer United (http://www.cancerunited.org/), has received funding from Roche, the world's leading maker of anticancer drugs. The public relations firm Weber Shandwick is providing logistical support.
John Smyth, Cancer United's chairman, who is professor of medical oncology in Edinburgh and also the president of the Federation of European Cancer Societies, said that he had approached Roche …